Another update on the FDA’s war on natural medicine. Action Alert! Recently we told you about the Nov. 20-21 meeting of the FDA’s Pharmacy Compounding Advisory Committee (PCAC), in which the committee would recommend whether several natural medicines could continue to be used by pharmacies to make customized natural medicines for patients. The fate of… Continue reading Customized Resveratrol Also to Be Banned
Category: Health Autonomy
Fish Oil Import Ban: Update
The International Trade Commission (ITC) refused to hear the case; Amarin appeals. From Nutraingredients: Amarin Pharmaceuticals Inc. has appealed the decision by the US International Trade Commission not to hear its case in which it had sought to prevent the import of some omega-3 dietary supplements. The company also filed a technical writ to try… Continue reading Fish Oil Import Ban: Update
Are You Getting Enough Vitamin D?
Definitely not, if you’re following the government’s recommendations. GrassrootsHealth, an organization dedicated to disseminating information about vitamin D research, has now confirmed a previous finding that the National Academy of Medicine (IOM), the government’s advisor on health and medical issues, is off by a magnitude of ten in its recommended daily intake of vitamin D.… Continue reading Are You Getting Enough Vitamin D?
Fight Back Against the FDA’s Attack on Supplements
The agency is deciding what to do about “old” supplements—tell them what you think! Action Alert! Last year, we told you about the FDA’s massive attack on supplements that came in the form of a guidance document. That guidance is meant to provide clarity to supplement companies regarding “new supplements”—referred to as new dietary ingredients,… Continue reading Fight Back Against the FDA’s Attack on Supplements
Soon Big Brother Will Know If You Took Your Medicine
This opens the door to all kinds of scary possibilities. From ABC News: In a groundbreaking decision on Monday, the Food and Drug Administration approved a drug with a “digital ingestion tracking system,” which senses when a pill is swallowed and sends the data to a smartphone. The new drug/device combination product called Abilify MyCite… Continue reading Soon Big Brother Will Know If You Took Your Medicine
Individual Mandate Eliminated?
Lawmakers may still have a go at changing healthcare—through their tax plan. From The New York Times: Senate Republicans have decided to include the repeal of the Affordable Care Act’s requirement that most people have health insurance into the sprawling tax rewrite…. They also… revealed late Tuesday they would set all of their tax cuts… Continue reading Individual Mandate Eliminated?
Pharma Companies Sued Over MRI Drug
Will justice be done? From Business Wire: Chuck and Gena Norris announced today that they have filed a lawsuit against eleven drug companies, including McKesson and Bracco, that they claim are responsible for the gadolinium contrast dye used during the MRIs that nearly cost Gena her life. The lawsuit alleges that Gena was poisoned by… Continue reading Pharma Companies Sued Over MRI Drug
More Natural Medicines on FDA’s Chopping Block
The FDA’s Pharmacy Compounding Advisory Committee (PCAC) is holding another meeting, this time to decide the fate of resveratrol and pregnenolone, among other compounded medicines. Action Alert! For some time now, we’ve been monitoring the FDA’s PCAC as it recommends which substances should be allowed to be compounded. Almost always, PCAC follows the lead of… Continue reading More Natural Medicines on FDA’s Chopping Block
A Bill to Make Your Healthcare Charges Clearer
Will doctors and hospitals finally be required to disclose prices? Action Alert! although an overhaul of Obamacare seems off the table for the time being, a bill has been introduced in the House that includes a much-needed reform. As we’ve noted previously, there are countless horror stories about patients getting stuck with astronomical hospital bills,… Continue reading A Bill to Make Your Healthcare Charges Clearer
Another Alzheimer Drug Bites the Dust
Another potential blockbuster drug has flopped. Despite this, the feds still have natural alternative treatments in the crosshairs. From Forbes: Investors poured hundreds of millions of dollars into Axovant and its experimental Alzheimer’s drug, intepirdine. But in the end, the medicine was no different from 99% of medicines tested against the brain-wasting disease since 2002 — it… Continue reading Another Alzheimer Drug Bites the Dust